Baker Bros. Advisors LP 13D/13G Filings for Candel Therapeutics, Inc. (CADL)

Baker Bros. Advisors LP 13D and 13G filings for Candel Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-02-14
4:14 pm
Purchase
2024-12-3113GCandel Therapeutics, Inc.
CADL
Baker Bros. Advisors LP2,981,983
6.800%
2,981,983increase
(New Position)
Filing